v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 2,812 $ 3,498
Accounts receivable, net of allowance for credit loss of $26 and $0, respectively 5,006 4,983
Other current assets 1,598 1,841
Total current assets 9,416 10,322
Property and equipment, net 925 790
Operating lease right of use assets 1,756 1,864
Other long-term assets 45 45
Total assets 12,142 13,021
Current liabilities:    
Accounts payable 1,363 1,544
Accrued salary and bonus 878 1,969
Other accrued expenses 8,574 8,201
Note payable at fair value, current 7,498 5,100
Current liabilities of discontinued operations 660 660
Total current liabilities 18,973 17,474
Operating lease liabilities, net of current portion 1,359 1,472
Note payable at fair value 1,343 4,243
Other long-term liabilities 5,072 4,968
Total liabilities 26,747 28,157
Commitments and contingencies (Note 8)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,487,157 and 4,447,489 shares issued, respectively; 4,376,398 and 4,351,445 shares outstanding, respectively 406 405
Additional paid-in capital 188,224 188,146
Accumulated deficit (247,747) (248,215)
Treasury stock, at cost (110,759 and 96,044 shares, respectively) (2,024) (2,008)
Total stockholders’ deficit (61,141) (61,672)
Total liabilities and stockholders’ deficit (34,394) (33,515)
Total liabilities, preferred stock and stockholders’ deficit $ 12,142 $ 13,021

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL